NRXP
NRX Pharmaceuticals, Inc.Company with tickers: NRXP, NRXPW
CIK
1719406
CUSIP
629444209
Shares Outstanding
36,228,992
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $1,068,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Cost of Revenue | $631,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | $1,309,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Operating Income | $-4,742,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| Net Income | $-1,430,000 | USD | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Basic) | $-0.04 | USD/shares | 2026-03-31 | 10-Q | 2026-05-15 |
| EPS (Diluted) | — |